FFCP PHASE1:Mm9::chr12:114720632..114720643,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=50|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:114720632..114720643,-|id=chr12:114720632..114720643,-|ontology_enrichment_celltype=CL:0000553!3.32e-16!6;CL:0000556!3.32e-16!6;CL:0000050!9.96e-11!9;CL:0002031!4.52e-09!25;CL:0000414!9.93e-09!11;CL:0000839!2.42e-07!13;CL:0000988!7.96e-07!32;CL:0002032!7.96e-07!32;CL:0000037!7.96e-07!32;CL:0000566!7.96e-07!32;CL:0000837!7.96e-07!32|ontology_enrichment_celltype_v019_2=CL:0000084,1.94e-07,11;CL:0000827,1.94e-07,11;CL:0002031,4.44e-07,25;CL:0000838,6.76e-07,12|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001474!6.05e-08!22;UBERON:0004765!6.05e-08!22;UBERON:0001434!6.05e-08!22;UBERON:0007823!8.18e-08!5;UBERON:0002193!1.30e-07!48|ontology_enrichment_uberon_v019_2=UBERON:0000029,1.16e-18,1;UBERON:0001097,1.16e-18,1;UBERON:0003968,1.16e-18,1;UBERON:0001467,1.16e-18,1;UBERON:0002465,4.17e-07,3|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.333109761815663,0.404950534779652,0,1.10411757875383,0.959801035240171,0.42438965179803,0,4.17021995043718,6.79119451761232,0,0.22940928106717,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.838913030288682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.10725460376606,0,0,0,0,0,0,0,0,0.144599356919912,0,0,0.662524555381181,1.45462575940567,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241177159752417,0,0,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.341741761595705,0,0,0.188368457004691,0.27338845544205,0,0,0.139951452323658,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0962118416403295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.252697211763798,0,0,0,0,0,0,0,0,0,0,0,0,0,0.290692833264657,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421|short_description=p@chr12:114720632..114720643,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=50 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:114720632..114720643,- | |||
|description=CAGE_peak_at_chr12:114720632..114720643,- | |||
|id=chr12:114720632..114720643,- | |||
|ontology_enrichment_celltype=CL:0000553!3.32e-16!6;CL:0000556!3.32e-16!6;CL:0000050!9.96e-11!9;CL:0002031!4.52e-09!25;CL:0000414!9.93e-09!11;CL:0000839!2.42e-07!13;CL:0000988!7.96e-07!32;CL:0002032!7.96e-07!32;CL:0000037!7.96e-07!32;CL:0000566!7.96e-07!32;CL:0000837!7.96e-07!32 | |||
|ontology_enrichment_celltype_v019_2=CL:0000084,1.94e-07,11;CL:0000827,1.94e-07,11;CL:0002031,4.44e-07,25;CL:0000838,6.76e-07,12 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001474!6.05e-08!22;UBERON:0004765!6.05e-08!22;UBERON:0001434!6.05e-08!22;UBERON:0007823!8.18e-08!5;UBERON:0002193!1.30e-07!48 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000029,1.16e-18,1;UBERON:0001097,1.16e-18,1;UBERON:0003968,1.16e-18,1;UBERON:0001467,1.16e-18,1;UBERON:0002465,4.17e-07,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.333109761815663,0.404950534779652,0,1.10411757875383,0.959801035240171,0.42438965179803,0,4.17021995043718,6.79119451761232,0,0.22940928106717,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.838913030288682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.10725460376606,0,0,0,0,0,0,0,0,0.144599356919912,0,0,0.662524555381181,1.45462575940567,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241177159752417,0,0,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.341741761595705,0,0,0.188368457004691,0.27338845544205,0,0,0.139951452323658,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0962118416403295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.252697211763798,0,0,0,0,0,0,0,0,0,0,0,0,0,0.290692833264657,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.231867835620421 | |||
|short_description=p@chr12:114720632..114720643,- | |||
}} |
Latest revision as of 20:04, 4 August 2015
Short description: | p@chr12:114720632..114720643, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:114720632..114720643, - |
Coexpression cluster: | MCL_coexpression_mm9:50 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
T cell | 1.94e-07 | 11 |
pro-T cell | 1.94e-07 | 11 |
hematopoietic lineage restricted progenitor cell | 4.44e-07 | 25 |
lymphoid lineage restricted progenitor cell | 6.76e-07 | 12 |
Ontology term | p-value | n |
---|---|---|
lymph node | 1.16e-18 | 1 |
axillary lymph node | 1.16e-18 | 1 |
peripheral lymph node | 1.16e-18 | 1 |
shoulder | 1.16e-18 | 1 |
lymphoid system | 4.17e-07 | 3 |